期刊文献+

Primary biliary cirrhosis in HBV and HCV patients:Clinical characteristics and outcome 被引量:8

Primary biliary cirrhosis in HBV and HCV patients:Clinical characteristics and outcome
下载PDF
导出
摘要 AIM: To present the characteristics, management and outcome of patients with hepatitis B virus(HBV) or hepatitis C virus(HCV) infections concurrent with primary biliary cirrhosis(PBC).METHODS: Since January 2001 to September 2009,we retrospectively evaluated the medical records of all HBV(n = 1493) and HCV patients(n = 526) who are followed in our center for the presence of concurrent PBC. Seventeen patients identified with concurrent viral hepatitis and PBC(8 HCV and PBC; follow-up: 61 ± 37 mo and 9 HBV and PBC; follow-up: 57 ± 38 mo). PBC diagnosis was established if the patients met at least two of the following criteria: positivity for antimitochondrial antibody, elevated cholestatic enzymes and histological lesions of PBC.RESULTS: HCV or HBV diagnosis preceded that of PBC in most patients by many years. PBC diagnosis was based on the presence of antimitochondrial antibody and elevated cholestatic enzymes in all 17 patients,while one third(5/17; 29.4%) experienced severe pruritus many years before diagnosis. Patients with PBC and HBV were significantly younger at diagnosis of PBC compared to patients with PBC and HCV(56.1 ± 11.2vs 68.5 ± 10.3, respectively, P < 0.05). At initial clinical and histological assessment the majority of patients were cirrhotics(10/17; 58.8%) with the group of PBC and HCV carrying the highest frequency(87.5% vs33.3% in PBC and HBV; P < 0.05). The patients with HBV and concomitant PBC seem to have better outcome compared to those with HCV and PBC since none of the 6 non-cirrhotics with HBV and PBC developed cirrhosis during follow-up.CONCLUSION: PBC diagnosis in HBV or HCV patients is very difficult and usually delayed. Therefore, in any case, cholestasis should alert physicians to further search for PBC. AIM: To present the characteristics, management and outcome of patients with hepatitis B virus(HBV) or hepatitis C virus(HCV) infections concurrent with primary biliary cirrhosis(PBC).METHODS: Since January 2001 to September 2009,we retrospectively evaluated the medical records of all HBV(n = 1493) and HCV patients(n = 526) who are followed in our center for the presence of concurrent PBC. Seventeen patients identified with concurrent viral hepatitis and PBC(8 HCV and PBC; follow-up: 61 ± 37 mo and 9 HBV and PBC; follow-up: 57 ± 38 mo). PBC diagnosis was established if the patients met at least two of the following criteria: positivity for antimitochondrial antibody, elevated cholestatic enzymes and histological lesions of PBC.RESULTS: HCV or HBV diagnosis preceded that of PBC in most patients by many years. PBC diagnosis was based on the presence of antimitochondrial antibody and elevated cholestatic enzymes in all 17 patients,while one third(5/17; 29.4%) experienced severe pruritus many years before diagnosis. Patients with PBC and HBV were significantly younger at diagnosis of PBC compared to patients with PBC and HCV(56.1 ± 11.2vs 68.5 ± 10.3, respectively, P &lt; 0.05). At initial clinical and histological assessment the majority of patients were cirrhotics(10/17; 58.8%) with the group of PBC and HCV carrying the highest frequency(87.5% vs33.3% in PBC and HBV; P &lt; 0.05). The patients with HBV and concomitant PBC seem to have better outcome compared to those with HCV and PBC since none of the 6 non-cirrhotics with HBV and PBC developed cirrhosis during follow-up.CONCLUSION: PBC diagnosis in HBV or HCV patients is very difficult and usually delayed. Therefore, in any case, cholestasis should alert physicians to further search for PBC.
出处 《World Journal of Hepatology》 CAS 2013年第10期577-583,共7页 世界肝病学杂志(英文版)(电子版)
基金 Supported by the Research Committee of the University of Thessaly in part(Code No.2466)
关键词 Antimitochindrial ANTIBODIES AUTOIMMUNE liver disease HEPATITIS B VIRUS HEPATITIS C VIRUS Primary BILIARY cirrhosis. Antimitochindrial antibodies Autoimmune liver disease Hepatitis B virus Hepatitis C virus Primary biliary cirrhosis.
  • 相关文献

参考文献22

  • 1Kalliopi Zachou,Alexandros Sarantopoulos,Nikolaos K Gatselis,Themistoklis Vassiliadis,Stella Gabeta,Aggelos Stefos,Asterios Saitis,Panagiota Boura,George N Dalekos.Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threat[J].World Journal of Hepatology,2013,5(7):387-392. 被引量:6
  • 2K. Zachou,P. Muratori,G. K. Koukoulis,A. Granito,N. Gatselis,A. Fabbri,G. N. Dalekos,L. Muratori.Review article: autoimmune hepatitis – current management and challenges[J]. Aliment Pharmacol Ther . 2013 (8)
  • 3Nikolaos K. Gatselis,Kalliopi Zachou,Gary L. Norman,Stella Gabeta,Panagiotis Papamichalis,George K. Koukoulis,George N. Dalekos.Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease&ast;[J]. Autoimmunity . 2013 (7)
  • 4European Association for the Study of the Liver.EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection[J]Journal of Hepatology,2012(1).
  • 5Stella Gabeta,Gary L. Norman,Nikolaos Gatselis,Christos Liaskos,Panagiotis A. Papamichalis,Athanasios Garagounis,Kalliopi Zachou,Eirini I. Rigopoulou,George N. Dalekos.IgA Anti-b2GPI Antibodies in Patients with Autoimmune Liver Diseases[J]. Journal of Clinical Immunology . 2008 (5)
  • 6Marlyn J. Mayo.Natural History of Primary Biliary Cirrhosis[J]. Clinics in Liver Disease . 2008 (2)
  • 7Anna Linda Zignego,Alessia Piluso,Carlo Giannini.HBV and HCV chronic infection: Autoimmune manifestations and lymphoproliferation[J]. Autoimmunity Reviews . 2008 (2)
  • 8Aggelos Stefos,Nikolaos Gatselis,Kalliopi Zachou,Eirini Rigopoulou,Christos Hadjichristodoulou,George N. Dalekos.Descriptive epidemiology of chronic hepatitis B by using data from a hepatitis registry in Central Greece[J]. European Journal of Internal Medicine . 2008 (1)
  • 9Stella Gabeta,Gary L. Norman,Christos Liaskos,Panagiotis A. Papamichalis,Theodoros Zografos,Athanasios Garagounis,Eirini I. Rigopoulou,George N. Dalekos.Diagnostic Relevance and Clinical Significance of the New Enhanced Performance M2 (MIT3) ELISA for the Detection of IgA and IgG Antimitochondrial Antibodies in Primary Biliary Cirrhosis[J]. Journal of Clinical Immunology . 2007 (4)
  • 10N. K.GATSELIS,S. P.GEORGIADOU,G. K.KOUKOULIS,N.TASSOPOULOS,K.ZACHOU,C.LIASKOS,A.HATZAKIS,G. N.DALEKOS.Clinical significance of organ‐ and non‐organ‐specific autoantibodies on the response to anti‐viral treatment of patients with chronic hepatitis C[J]Alimentary Pharmacology & Therapeutics (鈥?),2006(11鈥?2).

二级参考文献26

  • 1Shigeru Kusumoto,Yasuhito Tanaka,Masashi Mizokami,Ryuzo Ueda.Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma[J]. International Journal of Hematology . 2009 (1)
  • 2Lok ASF,Liang RHS,Chiu EKW,et al.Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy: report of a prospective study. Gastroenterology . 1991
  • 3Yeo W,Chan PK,Zhong S,et al.Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. Journal of Medical Virology . 2000
  • 4Raimondo G,Pollicino T,Romanò L,Zanetti AR.A 2010 update on occult hepatitis B infection. Pathologie Biologie . 2010
  • 5Yeo W,Chan TC,Leung NW,Lam WY,Mo FK,Chu MT,Chan HL,Hui EP,Lei KI,Mok TS,Chan PK.Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. Journal of Clinical Oncology . 2009
  • 6Georgiadou SP,Zachou K,Liaskos CH,Gabeta S,Rigopoulou EI,Dalekos GN.Occult hepatitis B virus infection in patients with autoimmune liver diseases. Liver International . 2009
  • 7Ott JJ,Stevens GA,Groeger J,Wiersma ST.Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine . 2012
  • 8Evens AM,Jovanovic BD,Su YC,Raisch DW,Ganger D,Belknap SM,Dai MS,Chiu BC,Fintel B,Cheng Y,Chuang SS,Lee MY,Chen TY,Lin SF,Kuo CY.Rituximab-associated hepatitis B virus (HBV)reactivation in lymphoproliferative diseases:meta-analysis and examination of FDA safety reports. Annals of Oncology . 2011
  • 9Rehermann B,Ferrari C,Pasquinelli C,et al.The hepatitis B virus persists for decades after patients’ recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nature Medicine . 1996
  • 10European Association For The Study of The Liver.EASL clinical prac-tice guidelines:management of chronic hepatitis B virus infection. Journal of Hepatology . 2012

共引文献11

同被引文献43

引证文献8

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部